Choreo LLC Sells 638 Shares of Balchem Co. (NASDAQ:BCPC)

Choreo LLC cut its holdings in Balchem Co. (NASDAQ:BCPC) by 31.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,395 shares of the basic materials company’s stock after selling 638 shares during the period. Choreo LLC’s holdings in Balchem were worth $230,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of BCPC. Watts Gwilliam & Co. LLC boosted its stake in shares of Balchem by 63.7% during the 4th quarter. Watts Gwilliam & Co. LLC now owns 35,069 shares of the basic materials company’s stock worth $5,438,000 after acquiring an additional 13,642 shares in the last quarter. JPMorgan Chase & Co. boosted its position in Balchem by 1.7% during the third quarter. JPMorgan Chase & Co. now owns 458,986 shares of the basic materials company’s stock worth $80,782,000 after purchasing an additional 7,721 shares during the period. Stifel Financial Corp grew its holdings in Balchem by 26.2% during the third quarter. Stifel Financial Corp now owns 11,893 shares of the basic materials company’s stock valued at $2,093,000 after purchasing an additional 2,467 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Balchem by 3.1% in the third quarter. Geode Capital Management LLC now owns 928,904 shares of the basic materials company’s stock valued at $163,514,000 after purchasing an additional 27,979 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Balchem by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company’s stock worth $63,707,000 after buying an additional 7,562 shares during the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

Balchem Stock Up 1.0 %

Shares of BCPC stock opened at $164.82 on Friday. Balchem Co. has a 12 month low of $137.69 and a 12 month high of $186.03. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The firm has a market cap of $5.36 billion, a PE ratio of 44.31, a price-to-earnings-growth ratio of 4.42 and a beta of 0.69. The stock has a 50 day moving average of $163.46 and a 200-day moving average of $169.65.

Balchem Increases Dividend

The business also recently announced an annual dividend, which was paid on Friday, January 17th. Investors of record on Thursday, December 26th were paid a dividend of $0.87 per share. This is a boost from Balchem’s previous annual dividend of $0.79. This represents a yield of 0.4%. The ex-dividend date of this dividend was Thursday, December 26th. Balchem’s dividend payout ratio is presently 23.39%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on BCPC. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright raised their price target on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.